<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25421" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mycobacterium kansasii Infection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akram</surname>
            <given-names>Sami M.</given-names>
          </name>
          <aff>University of Florida, Gainesville</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawla</surname>
            <given-names>Prashanth</given-names>
          </name>
          <aff>Sovah Health, Martinsville, VA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sami Akram declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prashanth Rawla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25421.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mycobacterium kansasii is a slow-growing, non-tuberculosis mycobacterium (NTM) that, like other mycobacterial species, tends to cause six clinical patterns of infection: pulmonary disease, skin and soft tissue disease, musculoskeletal infections including monoarticular septic arthritis and tenosynovitis, disseminated disease, catheter-associated disease, and lymphadenitis. Chronic pulmonary cavitary disease in the upper lobe is the most common presentation of M. kansasii infections, and patients may be initially be misdiagnosed with pulmonary tuberculosis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the six main presentations of mycobacterium kansasii.</p></list-item><list-item><p>Describe pulmonary mycobacterium kansasii infection from pulmonary tuberculosis infection.</p></list-item><list-item><p>Explain the management options for mycobacterium kansasii infections.</p></list-item><list-item><p>Summarize interprofessional team strategies to improve care coordination and to enhance outcomes for patients affected by mycobacterium kansasii infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25421&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25421">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25421.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Mycobacterium kansasii</italic> is a non-tuberculosis mycobacterium (NTM) that is readily recognized based on its characteristic photochromogenicity; it produces a yellow pigment when exposed to light.</p>
        <p>Buhler and Pollack first described this slow-growing mycobacterium in 1953.<xref ref-type="bibr" rid="article-25421.r1">[1]</xref> Under light microscopy, <italic toggle="yes">M. kansasii</italic> appears as thick rectangular, beaded, gram-positive rods which are longer than those of <italic toggle="yes">M. tuberculosis</italic>.<xref ref-type="bibr" rid="article-25421.r2">[2]</xref> Clinically, <italic toggle="yes">M. kansasii</italic> causes a chronic, upper-lobe cavitary disease, resembling that from <italic toggle="yes">M. tuberculosis</italic>. The prevalence of NTM infections has steadily increased when compared to tuberculosis whose prevalence has decreased in the last few decades.<xref ref-type="bibr" rid="article-25421.r3">[3]</xref>&#x000a0;There is no clear data regarding the prevalence of&#x000a0;<italic toggle="yes">M.&#x000a0;kansasii</italic>, although&#x000a0;some studies have in fact shown decreasing prevalence.<xref ref-type="bibr" rid="article-25421.r4">[4]</xref></p>
      </sec>
      <sec id="article-25421.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Mycobacterium Kansasii</italic> is a slow-growing acid-fast bacillus. It grows best at 32 degrees Celcius, but can be cultured at 37 degrees. Its <italic toggle="yes">in-vitro</italic> and chemical characteristics are similar to those of <italic toggle="yes">M. marinum</italic> and <italic toggle="yes">M. szulgai</italic>&#x000a0;. It produces mature colonies in greater then&#x000a0;7 days. Like other mycobacteria in the family, <italic toggle="yes">M. kansasii</italic> is strictly a gram-positive, non-motile and non-spore-forming organism. Colony morphology ranges from flat to raised and smooth to rough. When grown in the dark <italic toggle="yes">M. kansasii</italic> colonies are at first non-pigmented but turn yellow after exposure to light due to deposition of beta-carotene crystals.<xref ref-type="bibr" rid="article-25421.r5">[5]</xref>&#x000a0;Microscopic examinations show&#x000a0;that when compared&#x000a0;to <italic toggle="yes">M. tuberculosis, M. </italic>kansasii<italic toggle="yes">&#x000a0;</italic>appears&#x000a0;longer and broader and are often beaded or cross-barred in appearance when stained with Ziehl Neelsen or Kinyoun stain.<xref ref-type="bibr" rid="article-25421.r6">[6]</xref> In Runyon classification, <italic toggle="yes">M. kansasii</italic> belongs to the group photochromogens. Biochemical characteristics include Catalase positive, nitrate reduction, tween hydrolysis, and urea hydrolysis. Identification using traditional methods could take as long as two months.</p>
        <p>Although <italic toggle="yes">M. Kansasii</italic> was long thought to be homogenous species, genetic studies have shown that there are at least seven subtypes, with subtype one being most frequently isolated in human infections.<xref ref-type="bibr" rid="article-25421.r7">[7]</xref> Pulsed-field gel electrophoresis techniques demonstrate that the clinical isolates are very closely related and may be clonal worldwide. Clinical isolates from Japan are similar those from Europe and USA. Pathogenic strains are highly Catalase positive.</p>
        <p><italic toggle="yes">M. kansasii</italic> is widely prevalent in the environment but has seldom been isolated from soil. Some documented sources include city tap water, swimming pools, fish tanks, fish bites, brackish water, and seawater.<xref ref-type="bibr" rid="article-25421.r8">[8]</xref>&#x000a0;Tap water appears to be the major reservoir. Infection is mostly acquired through the aerosol route. Infectivity is low in regions of endemicity. Transmission from humans to humans is not thought to occur, except in two&#x000a0;cases where familial clustering was noted.<xref ref-type="bibr" rid="article-25421.r9">[9]</xref> Clustering was thought to be due to a shared environment, susceptibility or genetic predisposition rather than true human to human transmission.<xref ref-type="bibr" rid="article-25421.r10">[10]</xref></p>
      </sec>
      <sec id="article-25421.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">M.&#x000a0;</italic>kansasii infection mostly occurs in males, at an average patient age of 45&#x02013;62&#x000a0;years.<xref ref-type="bibr" rid="article-25421.r11">[11]</xref> Lung infections caused by <italic toggle="yes">M. kansasii</italic> occur in geographic clusters.<xref ref-type="bibr" rid="article-25421.r12">[12]</xref> In the United States, <italic toggle="yes">M. kansasii</italic> infections are more common in southern and central states with the highest incidence seen in the southern states of Texas, Louisiana and Florida, as well as the central states of Illinois, Kansas, and Nebraska. <italic toggle="yes">M. kansasii</italic> infections are more likely to occur in urban areas than rural areas, and several studies have reported an association with mining practices.<xref ref-type="bibr" rid="article-25421.r13">[13]</xref> In the United Kingdom, <italic toggle="yes">M. kansasii</italic> infections are most frequent in Wales. Of all countries in Europe, Poland has the highest <italic toggle="yes">M. kansasii</italic> isolation rate (35% of all NTM compared to 5% in Europe).<xref ref-type="bibr" rid="article-25421.r4">[4]</xref><xref ref-type="bibr" rid="article-25421.r14">[14]</xref><xref ref-type="bibr" rid="article-25421.r4">[4]</xref></p>
        <p><italic toggle="yes">M. kansasii</italic> infections are also prevalent in areas where HIV infection is common due to the susceptibility of the hosts.</p>
        <p><italic toggle="yes">M. kansasii</italic> infections were the most common non-tuberculosis mycobacterial infections during the 1960s and 70s, before being surpassed by <italic toggle="yes">M.</italic>
<italic toggle="yes">avium-intracellulare</italic>. In the 80s with the rise of HIV infections, there was a resurgence of <italic toggle="yes">M. kansasii</italic>, which has now decreased in the antiretroviral therapy (AR) era. <italic toggle="yes">M.&#x000a0;kansasii</italic> infections can occur in both immunocompetent and immunosuppressed patients.<xref ref-type="bibr" rid="article-25421.r15">[15]</xref><xref ref-type="bibr" rid="article-25421.r16">[16]</xref>&#x000a0;In the 1980s the overall prevalence of <italic toggle="yes">M. kansasii</italic> infections was estimated to be 0.5 cases per 100,000 persons. Since mycobacterial infections are not reported, there is no reliable data for <italic toggle="yes">M. kansasii</italic> infections in transplant patients. Generally in transplant patients mycobacterial infections present as disseminated infections.<xref ref-type="bibr" rid="article-25421.r17">[17]</xref> Fifty percent of patients with pulmonary disease also have dissemination. Renal transplant patients have been the most frequently reported to have disseminated disease. <italic toggle="yes">M. abscesses, M. chelonae, </italic>and<italic toggle="yes"> M.kansasii</italic> are the mycobacteria most commonly present with dissemination. Even in HIV and late-stage AIDS patients<italic toggle="yes">, M. kansasii</italic> presents with pulmonary disease. In one study from California, the prevalence of mycobacterial infections was 0.75 /100 000 in HIV-negative patients, 115/100000 in HIV-positive patients, and 647/100000 persons in AIDS patients.<xref ref-type="bibr" rid="article-25421.r18">[18]</xref><xref ref-type="bibr" rid="article-25421.r19">[19]</xref></p>
      </sec>
      <sec id="article-25421.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Mycobacterial infections, including <italic toggle="yes">M. kansasii</italic> infections, can be categorized into six clinical patterns: pulmonary disease, skin, and soft tissues, musculoskeletal infections (monoarticular septic arthritis and tenosynovitis), disseminated disease, catheter-associated disease, and lymphadenitis.<xref ref-type="bibr" rid="article-25421.r20">[20]</xref> Chronic pulmonary cavitary disease in the upper lobe is the most common presentation of <italic toggle="yes">M. kansasii</italic> infections. Not surprisingly these patients may be initially diagnosed with pulmonary tuberculosis. In one study, the mean age of patients with <italic toggle="yes">M. kansasii</italic> infection was 58 years, and 64% were men. However, <italic toggle="yes">M. kansasii</italic> can infect adults of any age, sex, or race. Infection results in symptoms in 85% of cases.</p>
        <p>The most common symptoms of pulmonary <italic toggle="yes">M. kansasii</italic> infection include a cough (91%), sputum production (85%), weight loss (53%), breathlessness (51%), chest pain (34%), hemoptysis (32%), and fever or sweats (17%). Of all the NTM infections, M<italic toggle="yes">. kansasii</italic> infections most often resemble <italic toggle="yes">Mycobacterial tuberculosis</italic> infections.<xref ref-type="bibr" rid="article-25421.r21">[21]</xref> Risk factors for <italic toggle="yes">M. kansasii</italic> infections are the same as those for other mycobacteria, namely, smoking, pneumoconiosis, silicosis, chronic obstructive pulmonary disease, malignancy, immunosuppressed state, chronic kidney disease, alcoholism and concurrent or prior <italic toggle="yes">M. tuberculosis</italic> infection.<xref ref-type="bibr" rid="article-25421.r3">[3]</xref></p>
        <p>While cavitary disease occurs in 90% <italic toggle="yes">M. kansasiiI</italic> infections, nodular and brochiectatic disease can also occur. If left untreated pulmonary infections (both cavitary and nodular) are characterized by the persistence of AFB in the sputum and progressive destruction of the lung architecture. Pulmonary disease may be present in AIDS patients but there is less likelihood of cavitations; hilar lymphadenopathy and interstitial infiltrates are more common. However, if the CD4 count is high there is an increased chance of cavitary disease.</p>
        <p>The second most frequent organ involved in <italic toggle="yes">M. </italic>kansasii infection is the skin.<xref ref-type="bibr" rid="article-25421.r22">[22]</xref> Cutaneous infection resembles secondary to local lymphatic spread. Cutaneous lesions may include nodules, pustules, verrucous lesions, erythematous plaques, abscesses, and ulcers. In HIV and immunocompromised patients, the presentation can be atypical and include bacteremia, osteomyelitis, abscesses, and cellulitis. Pericarditis with cardiac tamponade has been reported in HIV patients.<xref ref-type="bibr" rid="article-25421.r23">[23]</xref></p>
        <p>In disseminated disease, the symptoms are vague and nonspecific. In a series of 49 patients, fever was present in 60%, hepatosplenomegaly in 40%; pulmonary infiltrates in 25% and lymphadenopathy in 10%. Bone involvement, such as vertebral osteomyelitis and sacroiliitis, is common with <italic toggle="yes">M. kansasii</italic> disseminated diseases. Psoas abscess, bone marrow granuloma, liver granuloma, and possible spleen abscesses have been described.</p>
        <p>In patients with an advanced immunocompromised state, HIV and&#x000a0;<italic toggle="yes">M.&#x000a0;kansasii</italic>&#x000a0;co-infection can occur and reported average CD count in these patients has been less than &#x0003c;50/mm3.<xref ref-type="bibr" rid="article-25421.r24">[24]</xref></p>
      </sec>
      <sec id="article-25421.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Since the symptoms are not specific and the differential diagnosis is broad, microbiologic isolation is required to make the diagnosis. <italic toggle="yes">M.&#x000a0;</italic>kansasii rarely represents colonization or environmental contamination. Therefore any isolation of the organism needs to be evaluated for therapy.<xref ref-type="bibr" rid="article-25421.r25">[25]</xref>&#x000a0;Highly sensitive and specific PCR tests are available for <italic toggle="yes">M.&#x000a0;</italic>kansasii.<xref ref-type="bibr" rid="article-25421.r26">[26]</xref><xref ref-type="bibr" rid="article-25421.r25">[25]</xref></p>
        <p>Culture results along with clinical and radiological diagnosis are&#x000a0;recommended for accurate diagnosis of <italic toggle="yes">M. </italic>kan<italic toggle="yes">sasii. </italic>As per the guidelines from ATS (American Thoracic Society) and IDSA (Infectious Disease Society of America) diagnosis of NTM should include a minimal radiological evaluation which includes a chest X-ray (or computed tomography of the chest&#x000a0;if there is an absence of cavitation), combined with positive sputum cultures and exclusion of other diagnoses clinically. Cultures are considered positive when two consecutive positive sputum cultures, one positive culture from bronchoscopy specimens, or one positive sputum culture with compatible pathology is present.<xref ref-type="bibr" rid="article-25421.r25">[25]</xref>&#x000a0;Cultures are considered to be positive when a) 2 sputum cultures are consecutively positive, b) bronchoscopy specimens with one positive culture or c) one sputum culture is positive and a compatible pathology is present.<xref ref-type="bibr" rid="article-25421.r25">[25]</xref></p>
      </sec>
      <sec id="article-25421.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Rifampin is the cornerstone of <italic toggle="yes">M kansasii</italic> therapy. The first line therapy recommended by IDSA-ATS guidelines for <italic toggle="yes">M. kansasii</italic> is rifampin, ethambutol, and isoniazid plus pyridoxine.<xref ref-type="bibr" rid="article-25421.r27">[27]</xref><xref ref-type="bibr" rid="article-25421.r28">[28]</xref><xref ref-type="bibr" rid="article-25421.r29">[29]</xref>&#x000a0;The recommended duration of therapy is at least 12 months or more with the goal to have culture negative results for 12 months on therapy. <italic toggle="yes">M. kansasii</italic> are predictably resistant to pyrazinamide. Isoniazid (INH) resistance should be interpreted with caution as a higher concentration is needed for <italic toggle="yes">M. kansasii</italic> when compared <italic toggle="yes">to M. tuberculosis</italic>. <italic toggle="yes">M. kansasii</italic> organisms show resistance to isoniazid at one mcg/mL but are susceptible at five mcg/mL. In a treatment na&#x000ef;ve patient, INH is effective regardless of concentration achieved in the serum. Rifampin-containing regimens have low failure rates (1.1%) and low long-term relapse rates (&#x0003c; 1%). Based on&#x000a0;<italic toggle="yes">M. kansasii&#x000a0;</italic>susceptibilities in vitro, patients with rifampin-resistant&#x000a0;<italic toggle="yes">M kansasii</italic>&#x000a0;disease should be treated with a 3-drug regimen, which should include clarithromycin or azithromycin. The other two drugs should be chosen from moxifloxacin, ethambutol, sulfamethoxazole, or streptomycin.<xref ref-type="bibr" rid="article-25421.r3">[3]</xref> The Clinical and Laboratory Standards Institute (CLSI) recommends that all initial isolates of <italic toggle="yes">M. kansasii</italic> be tested only for clarithromycin and rifampin susceptibility. INH and streptomycin susceptibility should be tested as secondary agents.</p>
        <p><italic toggle="yes">M.&#x000a0;</italic>kansasii in HIV patients:</p>
        <p>One strategy to treat <italic toggle="yes">M. kansasii </italic>infection in HIV-positive patients is to use an NRTI-based regimen, allowing for a full dose of rifampin, which is the cornerstone of therapy for <italic toggle="yes">M. kansasii</italic>. If a protease inhibitor (PI) such as darunavir or atazanavir or non-nucleoside reverse transcriptase inhibitor [NNRTI] such as efavirenz or nevirapine is included in HIV treatment regimens, rifabutin can be used instead of rifampin. Clarithromycin can be added to improve efficacy, but rifabutin-related toxicity can increase when combined with clarithromycin.</p>
        <p>Monitoring therapy:</p>
        <p>Serial sputum samples for AFB should be obtained regularly so patients failing therapy are recognized early and susceptibility testing for additional drugs can be done. Serial CXR can be administered, although lung disease is likely to evolve at a slow pace. Routine monitoring for adverse effects of medications and drug-drug interactions is recommended.</p>
      </sec>
      <sec id="article-25421.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Mycobacterium tuberculosis</p>
          </list-item>
          <list-item>
            <p>NTM other such as MAC</p>
          </list-item>
          <list-item>
            <p>Endemic fungi</p>
          </list-item>
          <list-item>
            <p>Actinomyces group</p>
          </list-item>
          <list-item>
            <p>Cancer</p>
          </list-item>
          <list-item>
            <p>Wegener&#x02019;s</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25421.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>With appropriate treatment, the prognosis is usually good.<xref ref-type="bibr" rid="article-25421.r30">[30]</xref>&#x000a0;Mortality is higher and can go up to&#x000a0;50% in patients with HIV who have <italic toggle="yes">M. </italic>kansasii&#x000a0;infection<italic toggle="yes">.<xref ref-type="bibr" rid="article-25421.r24">[24]</xref>&#x000a0;</italic>In HIV patients who have a pulmonary infection with<italic toggle="yes"> M. kansasii, s</italic>urvival predictors include higher CD4 cell count, negative smear microscopy, antiretroviral therapy and adequate treatment for&#x000a0;<italic toggle="yes">M. kansasii.<xref ref-type="bibr" rid="article-25421.r24">[24]</xref></italic></p>
      </sec>
      <sec id="article-25421.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Complications can include disseminated disease.&#x000a0;Bone involvement, such as vertebral osteomyelitis and sacroiliitis are common with&#x000a0;disseminated diseases.<xref ref-type="bibr" rid="article-25421.r31">[31]</xref>&#x000a0;Pneumothorax, Psoas abscess, bone marrow granuloma, liver granuloma, and possible spleen abscesses have also been described in the literature.<xref ref-type="bibr" rid="article-25421.r32">[32]</xref>&#x000a0;CNS complications like meningoencephalitis are very rare and are usually fatal.</p>
      </sec>
      <sec id="article-25421.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Pulmonology</p>
        <p>Infectious disease</p>
      </sec>
      <sec id="article-25421.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should know that the prognosis of&#x000a0;<italic toggle="yes">M. kansasii&#x000a0;</italic>is usually good when recognized and treated early. Treatment duration is long and the patients should adhere to the duration of the treatment as relapse rates are high if treatment is stopped early.</p>
      </sec>
      <sec id="article-25421.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Treatment is prolonged and requires meticulous monitoring, but M. kansasii is&#x000a0;a treatable infection. With rifampin-based regimens, the relapse rate is very low, and the prognosis is good. A study of 302 patients followed over more than a 50-year period (1952-1995), showed a mortality rate of 11%, but this included both immunocompromised and non-immunocompromised patients.</p>
      </sec>
      <sec id="article-25421.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of&#x000a0;<italic toggle="yes">M.&#x000a0;kansasii&#x000a0;</italic>requires an interprofessional effort from primary care physicians, pulmonologists and infectious disease specialists. Physicians and nurses should&#x000a0;educate the patient about being compliant with their medications. Ethambutol can cause visual disturbances. Rifampin is a strong&#x000a0;CYP3A4 Inducer and may decrease the serum concentrations or decrease the therapeutic effect of most multiple medications.&#x000a0;Pharmacists&#x000a0;should be aware of the drugs the patients are on and also explain to the patients about the side effects of medications used in the management of&#x000a0;<italic toggle="yes">M.&#x000a0;kansasii. </italic></p>
      </sec>
      <sec id="article-25421.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25421&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25421">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/mycobacterium-kansasii-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25421">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25421/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25421">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25421.s16">
        <fig id="article-25421.image.f1" position="float" orientation="portrait">
          <caption>
            <p><italic toggle="yes">Mycobacterium Kansasii</italic> Contributed by S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="My__kansasii" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25421.s17">
        <title>References</title>
        <ref id="article-25421.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BUHLER</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>POLLAK</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Human infection with atypical acid-fast organisms; report of two cases with pathologic findings.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1953</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>363</fpage>
            <page-range>363-74</page-range>
            <pub-id pub-id-type="pmid">13040295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukamura</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[A review on the bacteriology of Mycobacterium kansasii].</article-title>
            <source>Kekkaku</source>
            <year>1984</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>563</fpage>
            <page-range>563-7</page-range>
            <pub-id pub-id-type="pmid">6394864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maliwan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zvetina</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience.</article-title>
            <source>Postgrad Med J</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>81</volume>
            <issue>958</issue>
            <fpage>530</fpage>
            <page-range>530-3</page-range>
            <pub-id pub-id-type="pmid">16085747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoefsloot</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrejak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Angeby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bauriaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bemer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Beylis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boeree</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cacho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chihota</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chimara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Churchyard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cias</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Dekhuijzen</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Domingo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Drobniewski</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fauville-Dufaux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Folkvardsen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Mampaso</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Indra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jagielski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jong</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Leao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Macedo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manns&#x000e5;ker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Maugein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milburn</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Mlink&#x000f3;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Morcillo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Papaventsis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Palenque</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paez-Pe&#x000f1;a</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piersimoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Polanov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rastogi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ruiz-Serrano</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Simsek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van Soolingen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Szab&#x000f3;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>T&#x000f3;rtola Fernandez</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Totten</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Tyrrell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vasankari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Villar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walkiewicz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>D</given-names>
              </name>
              <collab>Nontuberculous Mycobacteria Network European Trials Group</collab>
            </person-group>
            <article-title>The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.</article-title>
            <source>Eur Respir J</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>1604</fpage>
            <page-range>1604-13</page-range>
            <pub-id pub-id-type="pmid">23598956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>David</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Biogenesis of beta-carotene in Mycobacterium kansasii.</article-title>
            <source>J Bacteriol</source>
            <year>1974</year>
            <month>Aug</month>
            <volume>119</volume>
            <issue>2</issue>
            <fpage>527</fpage>
            <page-range>527-33</page-range>
            <pub-id pub-id-type="pmid">4850775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bainomugisa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wampande</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Muchwa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Akol</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mubiri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ssenyungule</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matovu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ogwang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joloba</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.</article-title>
            <source>BMC Infect Dis</source>
            <year>2015</year>
            <month>Apr</month>
            <day>14</day>
            <volume>15</volume>
            <fpage>181</fpage>
            <pub-id pub-id-type="pmid">25884439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Iinuma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Molecular analysis of Mycobacterium kansasii isolates from the United States.</article-title>
            <source>J Clin Microbiol</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <page-range>119-25</page-range>
            <pub-id pub-id-type="pmid">14715741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collins</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Grange</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Mycobacteria in water.</article-title>
            <source>J Appl Bacteriol</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-211</page-range>
            <pub-id pub-id-type="pmid">6389461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Penny</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Two cases of Mycobacterium kansasii infection occurring in the same household.</article-title>
            <source>Tubercle</source>
            <year>1982</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-31</page-range>
            <pub-id pub-id-type="pmid">7179479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colombo</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Claypool</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Familial clustering of pulmonary nontuberculous mycobacterial disease.</article-title>
            <source>Chest</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>629</fpage>
            <page-range>629-34</page-range>
            <pub-id pub-id-type="pmid">19858235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shitrit</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Priess</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lavy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shitrit</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Raz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shlomi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Daniele</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.</article-title>
            <source>Chest</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>771</fpage>
            <page-range>771-6</page-range>
            <pub-id pub-id-type="pmid">16537880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adjemian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Falkinham</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Spatial clusters of nontuberculous mycobacterial lung disease in the United States.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>Sep</month>
            <day>15</day>
            <volume>186</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-8</page-range>
            <pub-id pub-id-type="pmid">22773732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Halsema</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Chihota</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Gey van Pittius</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>van Helden</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Churchyard</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.</article-title>
            <source>Biomed Res Int</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>959107</fpage>
            <pub-id pub-id-type="pmid">26180817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.</article-title>
            <source>Clin Chest Med</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-34</page-range>
            <pub-id pub-id-type="pmid">25676516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection.</article-title>
            <source>J Acquir Immune Defic Syndr</source>
            <year>2004</year>
            <month>Aug</month>
            <day>01</day>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>883</fpage>
            <page-range>883-9</page-range>
            <pub-id pub-id-type="pmid">15220694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohnishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kusumoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Satou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shirai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamaoka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hirose</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Adachi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Three cases of Mycobacterium kansasii pulmonary diseases in previously healthy young women].</article-title>
            <source>Nihon Kokyuki Gakkai Zasshi</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-31</page-range>
            <pub-id pub-id-type="pmid">21735743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lillo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orengo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cernoch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.</article-title>
            <source>Rev Infect Dis</source>
            <year>1990</year>
            <season>Sep-Oct</season>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>760</fpage>
            <page-range>760-7</page-range>
            <pub-id pub-id-type="pmid">2237115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bloch</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Zwerling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pletcher</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gerberding</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ostroff</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Vugia</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Reingold</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.</article-title>
            <source>Ann Intern Med</source>
            <year>1998</year>
            <month>Nov</month>
            <day>01</day>
            <volume>129</volume>
            <issue>9</issue>
            <fpage>698</fpage>
            <page-range>698-704</page-range>
            <pub-id pub-id-type="pmid">9841601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheu</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Jarlsberg</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Nahid</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Non-tuberculous mycobacterial infections at San Francisco General Hospital.</article-title>
            <source>Clin Respir J</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>436</fpage>
            <page-range>436-42</page-range>
            <pub-id pub-id-type="pmid">24799125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Raskine</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vettier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Colaitis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mechali</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bricaire</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bouvet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sadr</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Lalande</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Perronne</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review.</article-title>
            <source>Clin Infect Dis</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>1455</fpage>
            <page-range>1455-60</page-range>
            <pub-id pub-id-type="pmid">10585795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matveychuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fuks</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Priess</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hahim</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shitrit</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical and radiological features of Mycobacterium kansasii and other NTM infections.</article-title>
            <source>Respir Med</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>106</volume>
            <issue>10</issue>
            <fpage>1472</fpage>
            <page-range>1472-7</page-range>
            <pub-id pub-id-type="pmid">22850110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Razavi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cleveland</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous infection due to Mycobacterium kansasii.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-5</page-range>
            <pub-id pub-id-type="pmid">11109017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YL</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>E50</fpage>
            <page-range>E50-5</page-range>
            <pub-id pub-id-type="pmid">22823928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2004</year>
            <month>Oct</month>
            <day>01</day>
            <volume>170</volume>
            <issue>7</issue>
            <fpage>793</fpage>
            <page-range>793-8</page-range>
            <pub-id pub-id-type="pmid">15215152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Catanzaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gordin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Horsburgh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huitt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iademarco</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Iseman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ruoss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>von Reyn</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>K</given-names>
              </name>
              <collab>ATS Mycobacterial Diseases Subcommittee</collab>
              <collab>American Thoracic Society</collab>
              <collab>Infectious Disease Society of America</collab>
            </person-group>
            <article-title>An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2007</year>
            <month>Feb</month>
            <day>15</day>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-416</page-range>
            <pub-id pub-id-type="pmid">17277290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deggim-Messmer</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bloemberg</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Ritter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Voit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>H&#x000f6;mke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ttger</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations.</article-title>
            <source>EBioMedicine</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>9</volume>
            <fpage>228</fpage>
            <page-range>228-237</page-range>
            <pub-id pub-id-type="pmid">27333026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Management of disease due to Mycobacterium kansasii.</article-title>
            <source>Clin Chest Med</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>613</fpage>
            <page-range>613-21, vi</page-range>
            <pub-id pub-id-type="pmid">12370997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous Mycobacterial Disease Therapy: Take It to the Limit One More Time.</article-title>
            <source>Chest</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>150</volume>
            <issue>6</issue>
            <fpage>1177</fpage>
            <page-range>1177-1178</page-range>
            <pub-id pub-id-type="pmid">27938739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeStefano</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shoen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Cynamon</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Therapy for <italic>Mycobacterium kansasii</italic> Infection: Beyond 2018.</article-title>
            <source>Front Microbiol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>2271</fpage>
            <pub-id pub-id-type="pmid">30319580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.</article-title>
            <source>Clin Infect Dis</source>
            <year>2003</year>
            <month>Nov</month>
            <day>01</day>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>1178</fpage>
            <page-range>1178-82</page-range>
            <pub-id pub-id-type="pmid">14557961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Herwaarden</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bavelaar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Werre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dofferhoff</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Osteomyelitis due to Mycobacterium kansasii in a patient with sarcoidosis.</article-title>
            <source>IDCases</source>
            <year>2017</year>
            <volume>9</volume>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">28529884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25421.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boo</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>A Case of Pulmonary Mycobacterium kansasii Disease Complicated with Tension Pneumothorax.</article-title>
            <source>Tuberc Respir Dis (Seoul)</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>356</fpage>
            <page-range>356-9</page-range>
            <pub-id pub-id-type="pmid">26508923</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
